Paweł Tomczak, formerly President of the Management Board at Walmark, took over the position of Director of Foreign Markets in Aflofarm Farmacja Polska. The appointment of a new position is a harbinger of a new company development strategy on foreign markets.

Paweł Tomczak started his career in marketing in the FMCG industry. Over the past 15 years, he has held various positions in companies in the pharmaceutical industry. The first was US Pharmacia (later USP Zdrowie), where he spent six years in marketing going from Brand Manager position to Marketing Unit Director. In 2007, he took the position of Sales Director, assuming responsibility for all commercial activities of the company on the pharmacy market as well as non-pharmacy market. At the beginning of 2011, he joined the Sanofi Group as General Director of Nepentes S.A., which Sanofi bought a few months earlier. After a few months, he took over the whole OTC Sanofi business in Poland. In the second half of 2013, he was appointed the General Director of Walmark. He came to Aflofarm at the beginning of 2018.

The appointment of a new position is the announcement of Aflofarm's new development strategy on foreign markets:

Until now, the role of Aflofarm consisted primarily in attracting foreign distributors for our products. Thanks to this strategy, our products are already available in 30 countries around the world, including Europe, Asia, the United States, and the Middle East. Now we will strive to independently create our organization's structures outside the country, and to support the recognition and position of our brands in these markets, said Paweł Tomczak.